Weiwen Ying

Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy

Weiwen Ying, Zhenjian Du, Lijun Sun et al. · Molecular Cancer Therapeutics · 2011 · 231 citations

Medicine, Oncology, Pharmacology +11

Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in <i>In Vitro</i> and <i>In Vivo</i> Models of Non–Small Cell Lung Cancer

Takeshi Shimamura, Samanthi A. Perera, Kevin P. Foley et al. · Clinical Cancer Research · 2012 · 166 citations

Medicine, Oncology, Pharmacology +13

The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors

Tzu‐yin Lin, Misty D. Bear, Zhenjian Du et al. · Experimental Hematology · 2008 · 109 citations · Full text

Medicine, Oncology, Pharmacology +5

Indole- and indolizine-glyoxylamides displaying cytotoxicity against multidrug resistant cancer cell lines

David A. James, Keizo Koya, Hao Li et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 105 citations

Medicine, Medicinal Chemistry, Pharmacology +12

The novel HSP90 inhibitor STA‐1474 exhibits biologic activity against osteosarcoma cell lines

Jennifer McCleese, Misty D. Bear, Stacey Fossey et al. · International Journal of Cancer · 2009 · 81 citations

Medicine, Oncology, Pharmacology +16